Developing a new nanoemulsion drug product for herpes simplex virus treatment
Official title: Task V23: Storage and product formulation (Formulation of gD2 Nanoemulsion Drug Product)
Funded at Advanced Bioscience Laboratories, INC. · NIH-10265801 · Data updated 2026-11-12
This study is working on a new treatment for herpes simplex virus infections that uses tiny droplets to make the medicine more effective, giving patients a better option for managing their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $689,419 |
| NIH project number | 272201800009I-0-759302000003-1 |
| Project ID | NIH-10265801 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with herpes simplex virus infections who are seeking new treatment alternatives.
✕Less likely to help
Patients who do not have herpes simplex virus infections or those who are not eligible for clinical trials may not benefit from this research.
What this research studies
This research focuses on formulating a nanoemulsion drug product aimed at treating herpes simplex virus infections. The approach involves optimizing the drug formulation to enhance its effectiveness and ensure compliance with regulatory standards for clinical trials. Patients may benefit from a new treatment option that could improve outcomes for those affected by herpes simplex infections. The research includes comprehensive planning, development, and manufacturing processes to create a viable vaccine or biologic.
Why it matters
Potential benefit: If successful, this research could provide a new and effective treatment option for patients suffering from herpes simplex virus infections.
How similar studies have gone: Other research has shown success in developing novel drug formulations for infectious diseases, indicating potential for this approach.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.